Shenzhen Chipscreen Biosciences Co Net debt/EBITDA
Что обозначает Net debt/EBITDA в Shenzhen Chipscreen Biosciences Co?
Net debt/EBITDA Shenzhen Chipscreen Biosciences Co., Ltd. является 5,565.30
Какое определение для Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA компаний в Health Care сектор на SSE по сравнению с Shenzhen Chipscreen Biosciences Co
Что делает Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Компании с net debt/ebitda похож на Shenzhen Chipscreen Biosciences Co
- Mechel PJSC имеет Net debt/EBITDA из 3,412.93
- MAN SE имеет Net debt/EBITDA из 3,439.00
- Cresud имеет Net debt/EBITDA из 3,527.59
- Dealnet Capital имеет Net debt/EBITDA из 3,642.37
- EPI () имеет Net debt/EBITDA из 4,336.87
- KT имеет Net debt/EBITDA из 4,758.28
- Shenzhen Chipscreen Biosciences Co имеет Net debt/EBITDA из 5,565.30
- Aemetis Inc имеет Net debt/EBITDA из 6,195.62
- TTL Beteiligungs- und Grundbesitz-AG имеет Net debt/EBITDA из 6,283.54
- Prospect Resources имеет Net debt/EBITDA из 6,818.24
- Enel Chile S.A имеет Net debt/EBITDA из 7,379.66
- Boeing Co имеет Net debt/EBITDA из 7,664.71
- SK Telecom Co Ltd имеет Net debt/EBITDA из 7,844.35